Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux Disease

This study has been completed.
Information provided by:
Head and Neck Surgery Associates Identifier:
First received: September 15, 2005
Last updated: September 21, 2010
Last verified: September 2010
Results First Received: August 10, 2010  
Study Type: Interventional
Study Design: Allocation: Non-Randomized;   Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Conditions: Nasal Polyps
Gastroesophageal Reflux
Intervention: Drug: lansoprazole

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Lansoprazole Lansoprazole 30mg BID for one year

Participant Flow:   Overall Study

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Lansoprazole Lansoprazole 30mg BID for one year

Baseline Measures
Overall Participants Analyzed 
[Units: Participants]
[Units: Participants]
<=18 years   0 
Between 18 and 65 years   20 
>=65 years   0 
[Units: Participants]
Female   12 
Male   8 
Region of Enrollment 
[Units: Participants]
United States   20 

  Outcome Measures

1.  Primary:   Presence of Reflux in Patients With Polyposis   [ Time Frame: one year ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Scott Phillips
Organization: Head and Neck Surgery Associates
phone: 317-926-1056


Responsible Party: Scott Phillips MD, Head and Neck Surgery Associates Identifier: NCT00215787     History of Changes
Other Study ID Numbers: 2005-0165
Study First Received: September 15, 2005
Results First Received: August 10, 2010
Last Updated: September 21, 2010